Accelerating the creation of a smoke-free future
Despite the widespread knowledge that smoking is harmful, 1.2 billion people worldwide continue to smoke combustible cigarettes. Diseases and deaths associated with smoking are amongst the most preventable. The psychoactive drug nicotine makes cigarettes highly addictive however it is the other chemical compounds observed in cigarette smoke that causes the death of 8 million smokers a year.
At Broughton, we are passionate about ensuring that smokers around the world have the opportunity to switch to a range of alternative nicotine delivery products that are less harmful. Our mission is to drive a smoke-free future. For us, that means helping manufacturers assess their reduced harm nicotine products and navigate the most suitable regulatory pathways to ensure that these products get to the market. Broughton regulatory experts and scientists have been involved in several successful PMTA, TPD, TRPR, MRTP, and MAA regulatory submissions for reduced harm nicotine products.
At Broughton, we understand that innovation in a regulated marketplace can be challenging. Our team of device engineers and formulation experts are here to help you realize any concepts you may have in the Next Generation Nicotine Delivery Product (NGP) space, as well as optimize your prototype products to ensure that they are designed appropriately to deliver against global regulatory standards.
Helping to shape the future
Our team of leading scientific and regulatory experts across the global nicotine market are here to help you navigate through the product life cycle journey for your chosen regulatory pathway, these include:
Our experienced team have worked on major tobacco harm reduction regulatory projects to enable smokers to access scientifically substantiated reduced-risk products and is ready to advise you on tailor-made scientific strategies in areas including product development, regulatory submissions and post marketing surveillance activities.
Helping innovative companies get their Next Generation Nicotine Delivery Products (NGPs) to market
Helping to shape the future strategy of regulated Next Generation Nicotine Delivery Product (NGP) markets
Understanding clients needs and scoping the journey ahead
Maintaining and keeping your product on the market
Our integrated laboratory services provide scientific support and data generation for your NGP project
Understanding the chemistry of your Next Generation Nicotine Delivery Products (NGPs)
Understand and reduce the health risks of your Next Generation Nicotine Delivery Products (NGPs)
Understand the potential human health impact of your Next Generation Nicotine Delivery Products (NGPs)
No video selected
Select a video type in the sidebar.
Discover our videos, brochures, infographics and much more
Learn how our scientific experience and technical capabilities can help accelerate your pharmaceutical drug or device development project across different stages.
Learn how we can help reduce costs and increase speed by enabling the right decision at key moments to avoid costly mistakes, delays, or reworks later in the project.
Welcome to our Media Centre
Broughton is keen to discuss and share how science and innovation are enhancing lives. Check out the latest press releases for recent updates and developments, and review content and articles by our team of experts in Next Generation Nicotine Delivery Products (NGP’s).
We keep up to date with industry regulations and are advocates for best practices in the industry. Events are a great way for the industry to build knowledge, network and share experiences. Below is a list of events that will have a Broughton presence where we would love you to meet our team and discuss your analytical, scientific and regulatory projects.
From basic questions to complex compliance inquiries, we're here to help! Contact us today.